MZP-54

N/A

Report date: 2022/12/28 16:54:40
NME

Base Information

Drug NameMZP-54
Drug Alias NameMZP-54
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionBromodomain-containing protein 3 inhibitorsBromodomain-containing protein 4 inhibitorsProteolysis
TargetsBromodomain-containing protein 3Bromodomain-containing protein 4
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Dundee
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Dundee
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A